Cefilavancin
Cefilavancin (TD-1792) is an experimental antibiotic medication developed for the treatment of bacterial infections such as drug-resistant strains of Staphylococcus aureus.
≈ 1 min read
Cefilavancin. encyclopegia.org, snapshot enwiki-001370484191. /a/cefilavancin
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Cefilavancin (TD-1792) is an experimental antibiotic medication developed for the treatment of bacterial infections such as drug-resistant strains of Staphylococcus aureus. It is a prodrug which is also a codrug, injected intravenously and then cleaved inside the body to two active components, one of which is a modified form of vancomycin and the other a cephalosporin antibiotic.
In clinical trials cefilavancin has shown similar efficacy with reduced side effects compared to vancomycin itself.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370484191 under CC BY-SA 4.0; modifications have been made.